Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Glenmark Life Sciences Ltd - 543322 - Unaudited Financial Results For The First Quarter Ended June 30, 2021

 Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the First Quarter ended June 30, 2021. The said meeting of the Board commenced at 10.00 a.m. and concluded at 12.10 p.m. The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith. These are also being made available on the website of the Company at www.glenmarklifesciences.com You are requested to take the same on record.
13-08-2021
Bigul

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Enclosed please find herewith the details of Earnings Call slated for Monday, August 16, 2021 at 8:30 a.m. - 9:30 a.m. (IST), for your information and record. Please note that the recording of the call will be available on our website within 24 hours of the call.
09-08-2021

Glenmark Life Sciences slips below issue price as stock falls 5%

 On Friday, August 6, 2021, the company had made a quiet debut on the bourses as the shares listed at Rs 751.10 on the BSE
09-08-2021

Glenmark Life Sciences shares close with 4% gain in debut trade

 The company's market valuation was at Rs 9,167.48 crore on the BSE.
07-08-2021
Bigul

Glenmark Life Sciences Ltd - 543322 - Board Meeting Intimation for Results & Closure of Trading Window

 Glenmark Life Sciences Ltd has informed BSE regarding "Board Meeting Intimation for Results & Closure of Trading Window".
06-08-2021
Bigul

Glenmark Life Sciences Ltd - 543322 - Listing of equity shares of Glenmark Life Sciences Ltd

 Trading Members of the Exchange are hereby informed that effective from August 06, 2021, the equity shares of Glenmark Life Sciences Ltd (Scrip Code: 543322) are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. For further details please refer to the notice no 20210805-9 dated August 05, 2021.
06-08-2021

Glenmark Life Sciences IPO: What GMP signaling on last date of subscription

 Glenmark Life Sciences IPO: On account of overwhelming response from the bidders, Glenmark Life Sciences shares are doing well in the grey market
29-07-2021

Subscribe to Glenmark Life Sciences: Ajcon Global

 Ajcon Global has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 26, 2021.
27-07-2021
Close

Let's Open Free Demat Account